Grantham, Mayo, Van Otterloo & Co (GMO)’s CDK Global, Inc. CDK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-194,514
Closed -$12.1M 654
2017
Q2
$12.1M Buy
194,514
+63,225
+48% +$3.97M 0.07% 167
2017
Q1
$8.54M Buy
131,289
+79,753
+155% +$5.11M 0.05% 190
2016
Q4
$3.08M Buy
+51,536
New +$2.95M 0.02% 278

Other funds holding CDK

Grantham, Mayo, Van Otterloo & Co (GMO)'s CDK Position: Q3 2017 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of CDK Global, Inc. (CDK) in Q3 2017, closing a stake of 194,514 shares — an estimated $12.1M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CDK in Q4 2016 and held it in 3 quarters. The position peaked at $12.1M in Q2 2017. 555 funds tracked by Wall St. Rank hold CDK as of Q3 2017.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining CDK Global, Inc. position as of Q3 2017 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 194,514 CDK Global, Inc. shares in Q3 2017, an estimated $12.1M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CDK Global, Inc. in Q4 2016 and held it in 3 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s CDK Global, Inc. position peaked at $12.1M in Q2 2017.
  • 555 funds tracked by Wall St. Rank held CDK Global, Inc. as of Q3 2017.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2017, filed 14 Nov 2017.